In human patients, lethality from cancer is almost invariably due to the consequences of metastasis. Therefore, understanding the molecular pathways that underlie the emergence and growth of metastasis is of great biological and clinical significance. Our proposed studies of prostate carcinogenesis will investigate the stages of progression to metastatic disease, and will be facilitated by the design and analysis of """"""""next-generation"""""""" mouse models of advanced stages of prostate cancer that permit the identification, imaging, and molecular analysis of metastases. In our work, we will address fundamental questions concerning the origin and spread of metastatic disease, including: Do metastatic cells arise early or late in cancer progression? What is the basis for the tissue-selectivity of metastasis? What are the consequences of androgen ablation or surgical prostatectomy for metastasis? Are there metastasis-associated genes that specifically promote or suppress metastatic disease? What is the role of the epithelial-mesenchymal transition in metastasis? Our specific aims are: (1) Detection of metastatic cells in a mouse model of prostate cancer by lineage-marking of prostatic epithelium to examine the time course and tissue distribution of disseminated metastatic cells. (2) Whole-animal non-invasive imaging of metastatic disease through longitudinal studies of prostate cancer growth and metastasis using in vivo imaging techniques. (3) Molecular analysis of metastatic cells and identification of metastasis associated genes by gene expression profiling of isolated metastatic cells for the identification and functional investigation of genes up- and down-regulated in metastatic cancer. (4) Functional analysis of metastasis-associated genes in the prostate epithelium by inducible gene targeting approaches to determine whether candidate genes play a key role in progression to metastasis, with a focus on regulators of the epithelial-mesenchyrnal transition. Our studies should identify the rate-limiting steps in the metastatic cascade, visualize the spread of metastasis in vivo, and provide an entry-point to studying the molecular basis for its tissue-selectivity, all of which should have important implications for prostate cancer treatment.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA115985-03
Application #
7244452
Study Section
Tumor Progression and Metastasis Study Section (TPM)
Program Officer
Woodhouse, Elizabeth
Project Start
2005-07-01
Project End
2007-11-30
Budget Start
2007-05-01
Budget End
2007-11-30
Support Year
3
Fiscal Year
2007
Total Cost
$287,432
Indirect Cost
Name
University of Medicine & Dentistry of NJ
Department
Pediatrics
Type
Schools of Medicine
DUNS #
617022384
City
Piscataway
State
NJ
Country
United States
Zip Code
08854
Puzio-Kuter, Anna M; Castillo-Martin, Mireia; Kinkade, Carolyn W et al. (2009) Inactivation of p53 and Pten promotes invasive bladder cancer. Genes Dev 23:675-80
Yu, Xiuping; Wang, Yongqing; Jiang, Ming et al. (2009) Activation of beta-Catenin in mouse prostate causes HGPIN and continuous prostate growth after castration. Prostate 69:249-62
Leow, Ching Ching; Wang, Bu-Er; Ross, Jed et al. (2009) Prostate-specific Klf6 inactivation impairs anterior prostate branching morphogenesis through increased activation of the Shh pathway. J Biol Chem 284:21057-65
Placencio, Veronica R; Sharif-Afshar, Ali-Reza; Li, Xiaohong et al. (2008) Stromal transforming growth factor-beta signaling mediates prostatic response to androgen ablation by paracrine Wnt activity. Cancer Res 68:4709-18
Wang, Xi; Desai, Nishita; Hu, Ya-Ping et al. (2008) Mouse Fem1b interacts with the Nkx3.1 homeoprotein and is required for proper male secondary sexual development. Dev Dyn 237:2963-72
Ouyang, Xuesong; Jessen, Walter J; Al-Ahmadie, Hikmat et al. (2008) Activator protein-1 transcription factors are associated with progression and recurrence of prostate cancer. Cancer Res 68:2132-44
Zhang, Yongyou; Zhang, Jue; Lin, Yongshun et al. (2008) Role of epithelial cell fibroblast growth factor receptor substrate 2alpha in prostate development, regeneration and tumorigenesis. Development 135:775-84
Thomsen, Martin K; Butler, Christopher M; Shen, Michael M et al. (2008) Sox9 is required for prostate development. Dev Biol 316:302-11
Lin, Yongshun; Liu, Guoqin; Zhang, Yongyou et al. (2007) Fibroblast growth factor receptor 2 tyrosine kinase is required for prostatic morphogenesis and the acquisition of strict androgen dependency for adult tissue homeostasis. Development 134:723-34
Gao, Hui; Ouyang, Xuesong; Banach-Petrosky, Whitney A et al. (2006) Combinatorial activities of Akt and B-Raf/Erk signaling in a mouse model of androgen-independent prostate cancer. Proc Natl Acad Sci U S A 103:14477-82

Showing the most recent 10 out of 11 publications